Get the Stockscreener App
10.09
0.20%
0.02
Apogee Acquisition Corp stock is traded at $10.09, with a volume of 184.07K.
It is up +0.20% in the last 24 hours and down -0.10% over the past month.
Apogee Acquisition Corp is a blank check company.
See More
Previous Close:
$10.07
Open:
$10.09
24h Volume:
184.07K
Relative Volume:
2.79
Market Cap:
$236.81M
Revenue:
Net Income/Loss:
P/E Ratio:
-3,737.04
EPS:
-0.0027
Net Cash Flow:
1W Performance:
+0.20%
1M Performance:
-0.10%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$10.07
$10.09
52-Week Range:
$9.93
$10.10
Apogee Acquisition Corp Stock (AACP) Company Profile
Name
Apogee Acquisition Corp
Sector
Industry
Phone
771.210.4643
Address
2106 HOUSE AVE SUITE 375, CHEYENNE
Compare AACP vs VYLR, DMII, EVAC, BCSS, CEPF
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AACP
Apogee Acquisition Corp
|
10.09 | 236.81M | 0 | 0 | 0 | -0.0027 |
VYLR
Vylor Inc.
|
71.12 | 47.46B | 0 | 0 | 0 | 0.00 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.19 | 649.10M | 0 | 8.58M | -1.11M | 0.134 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.34 | 604.35M | 0 | 12.80M | -714.00K | 0.2184 |
BCSS
Bain Capital Gss Investment Corp
|
10.21 | 595.97M | 0 | 8.29M | -686.50K | 0.142 |
CEPF
Cantor Equity Partners Iv Inc
|
10.28 | 587.50M | 0 | 10.29M | -337.90K | 0.1801 |
Apogee Acquisition Corp Stock (AACP) Latest News
Apogee Acquisition Restates Q2 2026 Financials, Director and COO Resign - Minichart
Form 4 Apogee Acquisition Corp: APOGEE ACQUISITION SPONSOR LLC (10% Owner) For: 13 October - Investing.com Nigeria
Form 4 Apogee Acquisition Corp: Thomas Lloyd Watson (COO) For: 14 October - Investing.com Nigeria
Q2 errors surface at Apogee Acquisition (AACPR) as its COO and a director resign. - Stock Titan
Financial statements are unchanged as Apogee Acquisition Corp (AACPR) amends share and warrant counts. - Stock Titan
Pinnacle Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 25, 2026 - Yahoo Finance
Accelevation Launches Roadshow for Proposed IPO of 30 Million Shares - Yahoo Finance
Apogee Enterprises Director Julie K. Streich Receives 2,530 Shares in Award on September 11, 2026 - Kalkine Media
Apogee Enterprises Director Julie K. Streich Acquires 2,530 Shares at No Cost - Kalkine Media
abrdn Income Credit Strategies Fund cuts monthl... - Pluang
abrdn Income Credit Strategies Fund (ACP) Announces Change to Monthly Distribution Expected to Be Maintained for at Least the Next 12 Months - TradingView
abrdn Income Credit Strategies Fund cuts monthly distribution to $0.055 per share from $0.0775 - Bitget
Aperture AC to Take Atlantic HPC Public in $150 Million Deal - Yahoo Finance
Apogee Therapeutics (NASDAQ: APGE) leaves Nasdaq in AbbVie cash buyout - Stock Titan
Shareholders will receive $0.328125 per share on Sept. 30 - Stock Titan
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - Eastern Progress
AbbVie-owned Apogee Therapeutics (APGE) pulls unsold stock - Stock Titan
Apogee Therapeutics (APGE) director-linked funds fully exit in AbbVie deal - stocktitan.net
Apogee Therapeutics (APGE) CMO cashes out stock and options in AbbVie deal - Stock Titan
Director cashes out Apogee (NASDAQ: APGE) stake in AbbVie merger - Stock Titan
Apogee merger pays $135.11 per share in cash | APGE SEC FilingForm SCHEDULE 13D/A - stocktitan.net
AbbVie Finalizes $10.9 Billion Acquisition of Apogee Therapeutics, Initiates Nasdaq Delisting - Kalkine Media
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline - Dermatology Times
ACP/PA Stock Price and Chart — NYSE:ACP/PA - TradingView
AbbVie Completes Acquisition of Apogee Therapeutics - Investing News Network
AbbVie Completes $10.9 Billion Acquisition of Apogee Therapeutics - minichart.com.sg
AbbVie Completes $10.9 Billion Apogee Acquisition, Reaffirms 2026 EPS Guidance - Minichart
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio - TipRanks
AbbVie seals $11B acquisition of Apogee Therapeutics (ABBV:NYSE) - Seeking Alpha
AbbVie Completes Acquisition of Apogee Therapeutics - finance.yahoo.com
Apogee Therapeutics (APGE) CEO’s stock and options paid out in AbbVie deal - Stock Titan
AbbVie’s $10.9 billion deal adds a late-stage eczema treatment - Stock Titan
TOMI Regains Nasdaq Equity Compliance After $2.5M Debt Conversion - minichart.com.sg
ACP Edges Lower by 0.59%: abrdn Income Credit Strategies Fund Holds Above Key SupportRounding Top - dars.gov.et
abrdn Income Credit Strategies Fund (ACP) Ticks Up 1.39% as Shares Hold Above Key SupportIndex Put Call - vinanet.vn
ARISTEIA CAPITAL, L.L.C. Initiates Position in Apogee Acquisitio - GuruFocus
ABBV climbs around 1.5% after double-digit revenue growth and Apogee acquisition - Traders Union
Apogee Acquisition Corp Q2 2026: Net income $1.13M, EPS $0.08— 10-Q Summary - TradingView
Apogee Acquisition (AACP) faces 2027 deal-or-liquidation deadline - Stock Titan
Apogee Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Abrdn Income Credit Strategies Fund flagged as sell due to unsustainable yields and NAV erosion risks. - Pluang
ACP: NAV Erosion Will Continue (NYSE:ACP) - Seeking Alpha
AbbVie Raises $10 Billion in Debt to Fund Apogee Acquisition - Minichart
AbbVie Completes $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition - Kalkine Media
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com UK
AbbVie (NYSE: ABBV) issues new senior notes with Apogee-linked redemption - Stock Titan
AbbVie Inc Stock (ABBV) Closed Up by 3.48% on Aug 18: Key Drivers Unveiled - TradingKey
Osprey Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 21, 2026 - Yahoo Finance
Apogee Acquisition Corp SEC Filing (Aug 14, 2026) - Stock Titan
Apogee Acquisition Corp Stock (AACP) Financials Data
There is no financial data for Apogee Acquisition Corp (AACP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.00%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):